Amy Belt Raimundo is Managing Director of Kaiser Permanente Ventures. She is also currently an Independent Board Director at NuVasive Inc (NASDAQ: NUVA). Amy has a 15 year history of venture investing in medtech, diagnostics, healthcare information technology and digitized services including with Advanced Technology Ventures, Covidien Ventures and Convey Capital. In those roles, she has led diligence, made investments and assumed board roles in over 20 companies. Amy has also held a variety of operating roles including Chief Business Officer at Evidation Health, interim general management at Covidien, VP Reimbursement for Endogastric Solutions and multiple product management roles at Guidant Corporation. She spent several years as a management consultant at APM/CSC Healthcare where she optimized clinical guidelines, staffing and workflows for major health systems. Amy is a Kauffman Venture Fellow and holds a BA in Economics from Yale University and an MBA from the University of California at Berkeley.